Format

Send to

Choose Destination
Dis Markers. 2009;26(5-6):217-25. doi: 10.3233/DMA-2009-0646.

Markers of inflammation and risk of coronary heart disease.

Author information

1
Section of Population Health, University of Aberdeen, UK Department of Public Health and Primary Care, University of Cambridge, UK. n.sarwar@abdn.ac.uk

Abstract

Cardiovascular disease is the leading cause of global mortality, with coronary heart disease (CHD) its major manifestation. Although inflammation, the body's response to noxious stimuli, is implicated in several stages of CHD development, the relevance of circulating levels of markers of inflammation to CHD risk remains uncertain. This review summarizes available epidemiological evidence for four emerging inflammatory markers implicated in CHD (fibrinogen, C-reactive protein, lipoprotein-associated phospholipase A2 and interleukin-6); considers their likely utility in cardiovascular risk prediction; and outlines areas of outstanding uncertainty.

PMID:
19773611
PMCID:
PMC3833412
DOI:
10.3233/DMA-2009-0646
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center